Triple Green Farms CBD Gummies Face Consumer Scrutiny Over Labels And Pricing

Triple Green Farms CBD Gummies Face Consumer Scrutiny Over Labels And Pricing

Consumer Review Raises Questions About Triple Green Farms CBD Gummies

A buyer-focused review of Triple Green Farms CBD Gummies was published in Chicago on November 17, 2026, examining the product’s labeling, pricing, and purchase terms.

Triple Green Farms CBD Gummies is a hemp-derived CBD gummy sold direct by the brand, according to the company’s order page. The review noted that the product is not a drug and has not been approved by the FDA.

The displayed product label reads Full Spectrum Hemp Extract, 500MG per bottle, 25MG CBD per gummy, 20 count, gluten free and 100% vegan, under the phrase “Herbal Nutrition.” The review pointed out that 20 gummies at 25MG each comes to 500MG per bottle, making the brand’s figures internally consistent.

However, the review stated these are brand-provided label figures, not independently verified measurements. It also found that the reviewed materials do not substantiate the advertised extraction methods, filtration technology, certification claims, or country-of-origin representations.

The brand also offers a “1000MG upgrade” at $9.99 more per bottle, according to its Terms. The materials do not say how that upgrade is divided across gummies, and the review declined to guess.

Unverified Health Claims In Brand Materials

The brand states that CBD is absorbed quickly and that results build with continued use.

The page connects the product to a long list of health and wellness benefits, including several tied to specific conditions, which the review declined to repeat. It also presents percentage improvements for several measures and refers to “over 20,000 clinical studies.”

No study, population, dose, or product is named for any of those figures, the review found. The page also says the oil used in “the study” exceeds that study’s potency, without identifying the study.

The review emphasized that research on a compound in general is different from testing of a specific finished gummy. The materials reviewed show no trial of this finished product.

The FDA’s public consumer update on CBD says it has seen only limited data on CBD safety and notes that some CBD products are marketed with unproven medical claims.

Brand Terms And Buyer Takeaways

The brand’s own Terms state that the product is not intended to treat any medical condition and that the website information is educational. The review framed its findings as questions worth asking before ordering rather than reasons to avoid the product.

It advised shoppers that when the brand makes a claim, the wording “according to the company” applies, and when no source was found, that is stated plainly.

Related Stories

Friday
administrator
Friday is a San Diego based writer covering cannabis news, culture, and business. Known for sharp analysis and clean reporting, Friday helps readers navigate the industry without the fluff. Every article is built on research, real sources, and a deep commitment to the cannabis community.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *